Skip to main content
letter
. 2021 Mar 19;88:144–146. doi: 10.1016/j.ejim.2021.03.018

Table 1.

Patients’ characteristics and treatment details. .

Variable First wave(N = 1) Second wave(N = 13)
Age, years 75 72 (65 – 76)
Male sex Male 12 (92.3)
CPAP Yes 7 (53.8)
Steroid therapy
  • -

    Dexamethasone

  • -

    Prednisone

 No 13 (100)
  • -

    12 (92.3)

  • -

    1 (7.7)
LMWH (4000 IU enoxaparin) Yes 13 (100)
Antibiotic therapy Yes 9 (69.2)
HCQ (400 mg daily) Yes 0 (0.0)
Biologics
  • -

    Tocilizumab (400 mg)

  • -

    Anakinra (10 mg/kg)

 No 5 (38.5)
  • -

    1 (7.7)

  • -

    4 (30.8)
Comorbidities
  • -

    COPD

  • -

    ILD

  • -

    DM

  • -

    Cancer

 Yes:
  • -

    Yes

  • -

    No

  • -

    No

  • -

    No

 3 (23.1)
  • -

    1 (7.7)

  • -

    0 (0.0)

  • -

    1 (7.7)

  • -

    2 (13.4)

Continuous variables are presented as median and interquartile range, while categorical variables are presented as number and percentages.

CPAP: continuous positive airway pressure; COPD: chronic obstructive pulmonary disease; DM: type-2 diabetes mellitus; HCQ: hydroxychloroquine; ILD: interstitial lung disease; IU: international units; LMWH: low molecular weight heparin.